Michael Wallisch (M Wallisch)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Sickle Cell Disease

Pulmonary Embolism

Top Venues

Communications medicine

Cellular and molecular bioengineering

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Norah G Verbout, Christina U Lorentz, Brandon D Markway, Michael Wallisch, Thomas C Marbury, Enrico Di Cera, Joseph J Shatzel, András Gruber, Erik I Tucker
Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial. Communications medicine 4 (1) (2024)
Erica M Sparkenbaugh, Michael W Henderson, Megan D Miller-Awe, Christina Abrams, Anton Ilich, Fatima Trebak, Nirupama Ramadas, Shantel A Vital, Dillon Bohinc, Kara Bane, Chunsheng Chen, Margi Patel, Michael Wallisch, Thomas Renne, Andras Gruber, Brian Cooley, David Gailani, Malgorzata Kasztan, Gregory M Vercellotti, John D Belcher, Felicity N E Gavins, Evi X Stavrou, Nigel S Key, Rafal Pawlinski
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood (2023)
Erica M Sparkenbaugh, Michael W Henderson, Megan D Miller-Awe, Christina Abrams, Anton Ilich, Fatima Trebak, Nirupama Ramadas, Shantel A Vital, Dillon Bohinc, Kara Bane, Chunsheng Chen, Margi Patel, Michael Wallisch, Thomas Renne, Andras Gruber, Brian Cooley, David Gailani, Malgorzata Kasztan, Gregory M Vercellotti, John D Belcher, Felicity N E Gavins, Evi X Stavrou, Nigel S Key, Rafal Pawlinski
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood (2023)
Erica M Sparkenbaugh, Michael W Henderson, Megan D Miller-Awe, Christina Abrams, Anton Ilich, Fatima Trebak, Nirupama Ramadas, Shantel A Vital, Dillon Bohinc, Kara Bane, Chunsheng Chen, Margi Patel, Michael Wallisch, Thomas Renne, Andras Gruber, Brian Cooley, David Gailani, Malgorzata Kasztan, Gregory M Vercellotti, John D Belcher, Felicity N E Gavins, Evi X Stavrou, Nigel S Key, Rafal Pawlinski
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood (2023)
Erica M Sparkenbaugh, Michael W Henderson, Megan D Miller-Awe, Christina Abrams, Anton Ilich, Fatima Trebak, Nirupama Ramadas, Shantel A Vital, Dillon Bohinc, Kara Bane, Chunsheng Chen, Margi Patel, Michael Wallisch, Thomas Renne, Andras Gruber, Brian Cooley, David Gailani, Malgorzata Kasztan, Gregory M Vercellotti, John D Belcher, Felicity N E Gavins, Evi X Stavrou, Nigel S Key, Rafal Pawlinski
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood (2023)
Christina U Lorentz, Erik I Tucker, Norah G Verbout, Joseph J Shatzel, Sven R Olson, Brandon D Markway, Michael Wallisch, Martina Ralle, Monica T Hinds, Owen J T McCarty, David Gailani, Jeffrey I Weitz, András Gruber
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood 138 (22) (2022)
Robert Silasi-Mansat, Ravi Shankar Keshari, Girija Regmi, Cristina Lupu, Constantin Georgescu, Joe H Simmons, Michael Wallisch, Tia C L Kohs, Joseph J Shatzel, Sven R Olson, Christina U Lorentz, Cristina Puy, Erik I Tucker, David Gailani, Sidney Strickland, András Gruber, Owen J T McCarty, Florea Lupu
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus. Blood 138 (2) (2021)
Tia C L Kohs, Christina U Lorentz, J Johnson, C Puy, S R Olson, J J Shatzel, David Gailani, Monica T Hinds, E I Tucker, András Gruber, Owen J T McCarty, Michael Wallisch
Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis. Cellular and molecular bioengineering 14 (2) (2020)
Michael Wallisch, Sven R Olson, Jeffrey Crosby, Jennifer Johnson, Susan F Murray, Joseph J Shatzel, Erik I Tucker, Owen J T McCarty, Monica T Hinds, Brett P Monia, András Gruber
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate. Cellular and molecular bioengineering 13 (3) (2020)
Michael Wallisch, Christina U Lorentz, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Marschelle R Carris, Cristina Puy, David Gailani, Monica T Hinds, Owen J T McCarty, András Gruber, Erik I Tucker
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates. Research and practice in thrombosis and haemostasis 4 (2) (2020)